When hepatitis C became curable in 2013, it felt like the battle had been won. The cure, however, had a challenge of its own.
Medication Adherence Strategies to Save Lives
The new wonder drugs were accompanied by an intensive, self-administered treatment regimen. Would patients comply? Compliance with treatment regimens is a challenge for the healthcare industry, with medication non-adherence affecting as many as 40%–50% of patients and causing an estimated 125,000 deaths each year. All avoidable.
With lives at stake, our client in the pharmaceutical industry asked our Design Insights and Strategy team to research solutions and devise a care model that would motivate patients with hepatitis C to complete the regimen successfully.
Let’s talk about how we can help move your business forward.
Contact us today to
start a discussion.